Salbutamol by Dragon Pharma

Dragon Pharma Original Formula

Salbutamol (Albuterol)

Salbutamol10 mg/tab
Class Beta-2 Agonist
Half-Life ~4–6 hours
Primary Action Bronchodilation / Lipolysis
Hormonal Effect None
Pack 100 tabs
Form Oral Tablet
Availability: In Stock
$60.00
Quantity
Shipping
Wishlist

Salbutamol (Albuterol) 10mg by Dragon Pharma

Salbutamol (known as Albuterol in the US) is Dragon Pharma's formulation of oral Salbutamol at 10mg per tablet — a short-acting beta-2 adrenergic agonist originally developed as a bronchodilator, used in performance contexts for its thermogenic, lipolytic and anti-catabolic properties. At 10mg per tablet, this is a high-dose oral formulation — significantly above standard asthma dosing — designed for users seeking the systemic beta-2 effects rather than bronchodilation alone.

Also searched as: Albuterol 10mg, Salbutamol tablets oral, Albuterol oral fat loss, Salbutamol Dragon Pharma.

Salbutamol vs Clenbuterol — The Critical Pharmacological Differences

Salbutamol and Clenbuterol are both beta-2 agonists and are frequently compared, but their pharmacological profiles differ in several important ways that affect how they are used:

Parameter Salbutamol (Albuterol) Clenbuterol
Beta receptor selectivity Highly beta-2 selective — minimal beta-1 activity Beta-2 predominant but less selective than Salbutamol
Half-life (oral) ~4–6 hours ~35–40 hours
Receptor downregulation Faster downregulation — receptors recover between doses due to short half-life Slower downregulation — long half-life maintains constant receptor occupation
Dosing frequency 3–4× daily for sustained effect Once daily (half-life too long for multiple doses)
2-week on/off cycling Less strictly required — short half-life allows partial receptor recovery between doses Required — continuous receptor occupation causes 50% downregulation within 2 weeks
Cardiovascular impact Generally considered milder — higher beta-2 selectivity means less beta-1 cardiac stimulation More pronounced cardiac effects at equivalent doses
Thermogenic potency Moderate — less potent per dose than Clenbuterol More potent thermogenic per dose

Why Salbutamol's Short Half-Life Changes the Receptor Dynamic

This is the most important pharmacological distinction and the least explained in competitor content:

  • Clenbuterol's ~35-40 hour half-life means it is present at active concentrations 24 hours a day — beta-2 receptors are continuously occupied, driving the well-documented 50% downregulation within 2 weeks that necessitates the 2-week on/off cycling protocol
  • Salbutamol's ~4-6 hour half-life means there are natural low-concentration windows between doses — beta-2 receptors are not continuously saturated and have time for partial recovery
  • The practical consequence: Salbutamol users often run it continuously without strict 2-week cycling, instead relying on the natural trough periods between doses to prevent the degree of receptor downregulation Clenbuterol produces
  • This does not mean receptor downregulation is absent with Salbutamol — it occurs, but at a slower and more manageable rate that the short half-life partially accommodates

Oral vs Inhaled Salbutamol — An Important Distinction

Salbutamol is most commonly known as an inhaled medication (Ventolin inhaler) for asthma. Oral Salbutamol at 10mg represents a fundamentally different application:

  • Inhaled Salbutamol reaches the airway at very low systemic concentrations — the goal is local bronchodilation with minimal systemic absorption. A standard inhaled dose is 100-200mcg, producing local airway effect with very little reaching systemic circulation
  • Oral Salbutamol at 10mg enters the bloodstream systemically — producing the full range of beta-2 effects throughout the body including adipose tissue (lipolysis), skeletal muscle (anti-catabolism), and the cardiovascular system
  • The dose difference is approximately 50-100× — 10mg oral vs 0.1-0.2mg inhaled — reflecting the different goals and pharmacokinetics of each route

Effects and Benefits

  • Thermogenic effect — increased basal metabolic rate via beta-2 receptor activation in adipose tissue (less potent than Clenbuterol per dose)
  • Lipolytic activity — hormone-sensitive lipase (HSL) activation driving fatty acid release from adipocytes
  • Anti-catabolic effect in skeletal muscle — beta-2 receptor activation reduces muscle protein breakdown via mTOR pathway stimulation, same mechanism as Clenbuterol
  • Bronchodilation — vasodilation of airways, improving oxygen delivery during training
  • Higher beta-2 selectivity than Clenbuterol — potentially milder cardiovascular side effects at equivalent anabolic doses
  • No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

Protocol Daily Dose Frequency Notes
Standard fat loss 16–32 mg/day 3–4× daily (4–8mg per dose) Split doses to maintain blood levels
Conservative start 8–16 mg/day 2–3× daily Assess tolerance before escalating

At 10mg per tablet, the Dragon Pharma formulation delivers a high per-tablet dose — the 10mg tablet is typically split for the lower doses or taken whole for higher-dose protocols. Due to the ~4-6 hour half-life, 3-4 daily doses maintain more stable blood levels than once-daily dosing would provide. Morning and pre-workout dosing is preferred for the later doses — the sympathomimetic stimulation affects sleep if taken in the evening.

Side Effects

  • Tremors — dose-dependent; beta-2 receptor stimulation in skeletal muscle causing involuntary contractions; typically reduces as receptor tolerance develops
  • Elevated heart rate — beta-2 agonism has some beta-1 cross-reactivity at higher doses despite Salbutamol's higher selectivity
  • Headaches — common at higher doses; related to vasodilation
  • Muscle cramps — same taurine depletion mechanism as Clenbuterol; taurine supplementation at 3-5g/day is recommended
  • Hypokalemia (low potassium) at high doses — beta-2 agonists drive potassium into cells; potassium supplementation may be needed at higher doses
  • No impact on testosterone, estrogen or the HPG axis — no PCT required

Salbutamol vs Clenbuterol — Which to Choose

  • Choose Salbutamol when: cardiovascular sensitivity to Clenbuterol is a concern; strict 2-week cycling is impractical; a more manageable receptor profile is preferred; airway performance during training is a specific goal
  • Choose Clenbuterol 40mcg when: maximum thermogenic potency per dose is the priority; once-daily dosing convenience is preferred; the 2-week on/off protocol is feasible

Building a Fat Loss Protocol Around Salbutamol

  • Testosterone Propionate or Enantat 250 as an AAS base to protect lean mass during caloric deficit
  • Anavar for additional anti-catabolic protection during aggressive cutting
  • Taurine 3-5g/day throughout to prevent muscle cramps
  • Potassium supplementation at higher doses to offset hypokalemia risk

"Salbutamol 10mg is formulated for systemic oral use — the same beta-2 mechanism as Clenbuterol with higher receptor selectivity and a shorter half-life that allows a different cycling approach and a potentially more manageable cardiovascular profile."

Storage and Handling

Store Salbutamol at room temperature, away from direct sunlight and moisture. Keep the original packaging sealed until use to maintain tablet potency.

Please log in to write review.

Both are beta-2 agonists with thermogenic and anti-catabolic effects, but differ significantly in half-life and receptor selectivity. Salbutamol is more beta-2 selective with a ~4-6 hour half-life requiring 3-4 daily doses. Clenbuterol has a ~35-40 hour half-life requiring only once-daily dosing but causing more pronounced receptor downregulation that necessitates strict 2-week on/off cycling.

Clenbuterol's long half-life means beta-2 receptors are continuously occupied 24 hours a day, driving approximately 50% downregulation within 2 weeks. Salbutamol's ~4-6 hour half-life creates natural low-concentration windows between doses where receptors partially recover. This partial recovery reduces the degree of downregulation compared to continuous Clenbuterol exposure, making strict cycling less necessary — though downregulation still occurs and dose rotation remains sensible.

No — they are the same compound but fundamentally different in dose and application. A standard inhaled Salbutamol dose (Ventolin) is 100-200 micrograms, targeting local airway bronchodilation with minimal systemic absorption. Oral Salbutamol at 10mg per tablet is approximately 50-100× that dose and enters the systemic circulation fully, producing the whole-body beta-2 effects used for fat loss and anti-catabolism.

For the same reason as Clenbuterol — both deplete taurine through increased urinary excretion. Taurine is required for calcium regulation in skeletal muscle; its depletion impairs this regulation, causing the involuntary cramps. Supplementing 3-5g taurine daily prevents this in most users.

Beta-2 agonists drive potassium ions from the blood into cells — reducing serum potassium levels (hypokalemia). At standard doses this effect is mild, but at the higher doses used for performance, it can become clinically relevant — manifesting as muscle weakness, palpitations or fatigue. Potassium supplementation at higher Salbutamol doses reduces this risk.

No — Clenbuterol is generally considered more potent per milligram for thermogenic effects. Salbutamol's advantage is its higher beta-2 selectivity (potentially milder cardiovascular impact) and shorter half-life (more flexible cycling). For maximum thermogenic effect per dose, Clenbuterol is more potent; for a more cardiovascularly manageable beta-2 agonist, Salbutamol is often preferred.

Related Products